Diagnostic value of serum soluble interleukin-2 receptor (SIL- 2R) and acute phase proteins levels (APP) in community acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003
Triggering receptor expressed on myeloid cells (TREM)-1 and its soluble form (sTREM-1) as a diagnostic marker of bacterial lung infection Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008
Clinical value of soluble interleukine-2 receptor (sIL-2R) serum level examination in the pulmonary sarcoidosis (PS) Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003
Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
The comparison of diagnostic relevance of protein C, C-reactive protein and endothelin-1 for prediction of lung vessel thrombosis in patients with community-acquired pneumonia Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019
Prognostic value of Fas ligand in patients with sepsis and septic shock Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019
Clinical value of measurements of interleukin-2 soluble receptor in blood of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002
Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Source: Eur Respir J 2003; 22: 57S-64S Year: 2003
Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008
Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 227s Year: 2002
The clinical significance of serum interleukin 18 concentration in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003
COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis severity Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity Year: 2008
Soluble form of CD95 (Fas/Apo-1) in patients with community-acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 320s Year: 2004
Role of progestrin releasing peptide (ProGRP), a serum based biomarker in early diagnosis of SCLC in cohort of high-risk patient presenting with symptoms related to lung cancer Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
The prognostic value of procalcitonin in patients with hypoxemic COVID 19 pneumonia. Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021
Serum kinetics of total leptin and soluble leptin receptor as prognostic tools in sepsis. Source: International Congress 2019 – Biomarkers, laboratory findings and pre-clinical data in acute respiratory failure Year: 2019
Evaluation of serum concentration of soluble interleukin-2 receptors (sIL-2R) in different respiratory tract diseases Source: Annual Congress 2009 - Pleural and parenchymal diseases Year: 2009
Variable tissue expression of transferrin receptors: relevance to acute respiratory distress syndrome Source: Eur Respir J 2003; 22: 335-341 Year: 2003